Granules India informs about company updates

08 May 2018 Evaluate

Granules India has informed that the US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India for Methocarbamol Tablet 500 mg and 750 mg. The approved ANDA is the bioequivalent and therapeutically equivalent to Reference Listed Drug (RLD) of Robaxin 500 mg and 750 mg of Auxilium Pharmaceuticals. LLC. Granules India intends to commercialise this product shortly.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

564.95 -6.25 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×